Anagin - Crunchbase Company Profile & Funding

Q: Where is Anagin's headquarters?

Anagin is located in Indianapolis, Indiana, United States.

Q: Who invested in Anagin?

Anagin has 2 investors including Elevate Ventures And National Institute of Neurological Disorders and Stroke.

Q: When was the last funding round for Anagin?

Anagin closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Anagin

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Anagin

CB Rank

291748

Anagin is developing first-in-class therapies for treating neuropsychiatric diseases.

Founded

obfuscation

Private

Venture - Series Unknown

Indianapolis, Indiana, United States

1-10

anagin.com/

Biotechnology

Health Care

Life Science

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Yvonne Lai: Co-Founder
Jaswant Gidda: Chief Executive Officer ,Chief R&d officer
Past Role: Naurex, Vice President, Research & Development

Details

Legal Name

Anagin Inc.

Operating Status

Active

Company Type

For Profit

Founders

Anantha Shekhar, Yvonne Lai

About the Company

Anagin provides disease-modifying and curative therapies for patients suffering from post-traumatic stress disorder (PTSD), traumatic brain injury, neuropathic pain, depression, Parkinson’s disease, and Alzheimer’s disease.

Phone Number

888-526-2446

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

First-in-Class Therapies for Neuropsychiatric Diseases

Development of novel targeted drug therapies addressing disrupted synaptic plasticity in the central nervous system to treat neuropsychiatric disorders.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Anagin	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Anagin	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Anagin	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Anagin	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Anagin	1	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Anagin	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Anagin	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Anagin	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Anagin	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Anagin	1	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Elevate Ventures	—	Venture Round - Anagin	—
Elevate Ventures	—	Venture Round - Anagin	—
Elevate Ventures	—	Venture Round - Anagin	—
Elevate Ventures	—	Venture Round - Anagin	—
Elevate Ventures	—	Venture Round - Anagin	—